WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1992011233) ARYLCYANOGUANIDINE DERIVATIVE, PRODUCTION THEREOF, AND POTASSIUM CHANNEL OPENING AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1992/011233    International Application No.:    PCT/JP1990/001657
Publication Date: 09.07.1992 International Filing Date: 19.12.1990
Chapter 2 Demand Filed:    26.06.1992    
IPC:
C07C 279/28 (2006.01)
Applicants: KANEBO, LTD. [JP/JP]; 17-4, Sumida 5-chome, Sumida-ku, Tokyo 131 (JP) (For All Designated States Except US).
NISHIMURA, Noriyasu [JP/JP]; (JP) (For US Only).
IWAMOTO, Takahiro [JP/JP]; (JP) (For US Only).
SUKAMOTO, Takayuki [JP/JP]; (JP) (For US Only).
YOSHIIZUMI, Kazuya [JP/JP]; (JP) (For US Only).
SEKO, Norihiko [JP/JP]; (JP) (For US Only).
YOSHINO, Kouichiro [JP/JP]; (JP) (For US Only)
Inventors: NISHIMURA, Noriyasu; (JP).
IWAMOTO, Takahiro; (JP).
SUKAMOTO, Takayuki; (JP).
YOSHIIZUMI, Kazuya; (JP).
SEKO, Norihiko; (JP).
YOSHINO, Kouichiro; (JP)
Agent: AKAOKA, Michio; Koei Building, 1-13, Awajimachi 2-chome, Chuo-ku, Osaka-shi, Osaka-fu 541 (JP)
Priority Data:
Title (EN) ARYLCYANOGUANIDINE DERIVATIVE, PRODUCTION THEREOF, AND POTASSIUM CHANNEL OPENING AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT
(FR) DERIVE D'ARYLCYANOGUANIDINE, SON PROCEDE DE PRODUCTION, ET AGENT D'OUVERTURE DE VANNES A POTASSIUM COMPRENANT LE DERIVE A TITRE D'INGREDIENT ACTIF
Abstract: front page image
(EN)N-(3-Chloro-5-cyanophenyl)-N'-cyano-N''-t-pentylguanidine remarkably useful as a potassium channel opening agent, particularly as a remedy for hypertension.
(FR)N-(3-Chloro-5-cyanophényl)-N'-cyano-N''-t-pentylguanidine exceptionnellement utile en tant qu'agent d'ouverture de vannes à potassium, et notamment en tant que remède pour l'hypertension.
Designated States: JP, KR, US.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)